<DOC>
	<DOC>NCT00616629</DOC>
	<brief_summary>The purpose of the study is to measure the effects of AZD1305 on cardiac electrophysiological properties and intracardiac pressures</brief_summary>
	<brief_title>Cardiac Electrophysiological Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Flutter</mesh_term>
	<criteria>Patients with atrial flutter (with a ventricular rate of &lt;100 beats/minute at enrolment), scheduled for curative catheter ablation Sinus rhythm at randomisation QTc (Fridericia, QTcF ) &gt;450 ms measured in sinus rhythm at randomisation, Serum potassium below 3.8 or above 5.0 mmol/L or plasma potassium below 3.6 or above 5.0 mmol/L QRS duration &gt;120 ms at randomisation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>